News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Cell Therapeutics, Inc. (CTIC) (CTI) to Update Pixuvri® Launch and Pacritinib Pivotal Trial Status at the Annual Rodman & Renshaw Global Investment Conference



9/7/2012 10:59:45 AM

SEATTLE, Sept. 7, 2012 /PRNewswire/ -- Cell Therapeutics, Inc. (CTI) (NASDAQ and MTA: CTIC) management will present at the Annual Rodman & Renshaw Global Investment Conference on Tuesday, September 11at 10:25 a.m. Eastern/ 4:25 p.m. Central European/ 7:25 a.m. Pacific time in the Starlight North room of the Waldorf-Astoria Hotel.

The presentation with slides will be webcast live and available for replay after the presentation. The webcast can be accessed at www.celltherapeutics.com.

Annual Rodman & Renshaw Global Investment Conference

CTI presentation: Tuesday, September 11, 2012

10:25 a.m. Eastern/ 4:25 p.m. Central European/ 7:25 a.m. Pacific

Starlight North, Waldorf-Astoria Hotel

Media contact:

Investors contact:

Cell Therapeutics, Inc.

Cell Therapeutics, Inc.

Dan Eramian

Ed Bell

T: 206.272.4343

T: 206.272.4345

F: 206.272.4434

E: invest@ctiseattle.com

E: deramian@ctiseattle.com

www.celltherapeutics.com/investors

www.celltherapeutics.com/press_room


SOURCE Cell Therapeutics, Inc.


Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES